{
  "retracted": false,
  "timestamp": 1584403200000,
  "updates": [
    {
      "timestamp": 1591757963894,
      "identifier": {
        "doi": "10.1212/wnl.0000000000008670"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000005067"
  },
  "journal": "Neurology",
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks"
}
